CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare Conference
26. November 2024 07:00 ET
|
CytoSorbents
CytoSorbents to Participate in the Piper Sandler 36th Annual Healthcare Conference. Management holding one-on-one meetings with investors
CytoSorbents to Report Third Quarter 2024 Operating and Financial Results
17. Oktober 2024 07:00 ET
|
CytoSorbents
CytoSorbents to Announce Q3 2024 Financial and Operating Results on November 7, 2024
CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference
27. August 2024 07:00 ET
|
CytoSorbents
PRINCETON, N.J., Aug. 27, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
CytoSorbents Reports Second Quarter 2024 Financial and Operational Results
13. August 2024 16:19 ET
|
CytoSorbents
New CFO Peter J. Mariani to succeed retiring CFO Kathleen P. BlochOn track for DrugSorb™-ATR U.S. FDA De Novo and Health Canada marketing submissions this quarterIn Q2 2024, increased product sales by...
CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
13. August 2024 16:18 ET
|
CytoSorbents
PRINCETON, N.J., Aug. 13, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
30. Juli 2024 02:00 ET
|
CytoSorbents
CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"
CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
29. Juli 2024 08:00 ET
|
CytoSorbents
CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"
CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress
17. Juli 2024 07:00 ET
|
CytoSorbents
CytoSorbents CEO Dr. Phillip Chan to highlight its innovative critical care and cardiac surgery blood purification therapy at AAPI Conference this weekend
$6.25+ Billion Blood Purification Devices/Equipment/Methods Market Insights, Competitive Landscape, and Forecasts 2024-2030
02. Juli 2024 09:29 ET
|
Research and Markets
Dublin, July 02, 2024 (GLOBE NEWSWIRE) -- The "Blood Purification Devices/Equipment/Methods - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ...
CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan
24. Juni 2024 07:00 ET
|
CytoSorbents
Taiwan FDA approval of CytoSorb brings powerful blood purification therapy to critically ill and cardiac surgery patients in the country